MX361600B - Identificación de anticuerpos humanos con maduración de afinidad. - Google Patents
Identificación de anticuerpos humanos con maduración de afinidad.Info
- Publication number
- MX361600B MX361600B MX2014000431A MX2014000431A MX361600B MX 361600 B MX361600 B MX 361600B MX 2014000431 A MX2014000431 A MX 2014000431A MX 2014000431 A MX2014000431 A MX 2014000431A MX 361600 B MX361600 B MX 361600B
- Authority
- MX
- Mexico
- Prior art keywords
- primers
- region
- nucleic acids
- amplified
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161506749P | 2011-07-12 | 2011-07-12 | |
| PCT/US2012/046431 WO2013009967A2 (en) | 2011-07-12 | 2012-07-12 | Identifying affinity-matured human antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014000431A MX2014000431A (es) | 2014-09-04 |
| MX361600B true MX361600B (es) | 2018-12-11 |
Family
ID=47506915
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014000431A MX361600B (es) | 2011-07-12 | 2012-07-12 | Identificación de anticuerpos humanos con maduración de afinidad. |
| MX2018015450A MX2018015450A (es) | 2011-07-12 | 2014-01-10 | Identificacion de anticuerpos humanos con maduracion de afinidad. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018015450A MX2018015450A (es) | 2011-07-12 | 2014-01-10 | Identificacion de anticuerpos humanos con maduracion de afinidad. |
Country Status (11)
| Country | Link |
|---|---|
| US (6) | US9234030B2 (enExample) |
| EP (2) | EP3034513B1 (enExample) |
| JP (1) | JP6731702B2 (enExample) |
| KR (1) | KR102139388B1 (enExample) |
| CN (2) | CN107090459A (enExample) |
| AU (2) | AU2012281078B2 (enExample) |
| CA (1) | CA2841475C (enExample) |
| IL (2) | IL230358B (enExample) |
| MX (2) | MX361600B (enExample) |
| RU (2) | RU2636045C2 (enExample) |
| WO (1) | WO2013009967A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2841475C (en) * | 2011-07-12 | 2021-02-09 | Xbiotech Inc. | Identifying affinity-matured human antibodies |
| WO2014144495A1 (en) | 2013-03-15 | 2014-09-18 | Abvitro, Inc. | Single cell bar-coding for antibody discovery |
| GB201316644D0 (en) * | 2013-09-19 | 2013-11-06 | Kymab Ltd | Expression vector production & High-Throughput cell screening |
| US10533204B2 (en) | 2014-05-30 | 2020-01-14 | National University Corporatlon University of Toyama | Method for amplifying a T cell receptor (TCR) cDNA |
| MX394895B (es) | 2014-06-03 | 2025-03-24 | Xbiotech Inc | Composiciones útiles para el tratamiento de infecciones por staphylococcus aureus. |
| US10590483B2 (en) | 2014-09-15 | 2020-03-17 | Abvitro Llc | High-throughput nucleotide library sequencing |
| US10975146B2 (en) | 2018-06-29 | 2021-04-13 | Cedars-Sinai Medical Center | Interleukin-1 inhibition for combination treatment of pancreatic cancer |
| US12703882B2 (en) * | 2019-06-14 | 2026-08-11 | The Regents Of The University Of California | Methods of sequencing antibody chains from hybridomas and kits for practicing same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001068682A1 (en) | 2000-03-10 | 2001-09-20 | Large Scale Biology Corporation | Self antigen vaccines for treating b cell lymphomas and other cancers |
| AU2002953381A0 (en) * | 2002-12-18 | 2003-01-09 | Diatech Pty Ltd | In vivo affinity maturation scheme |
| WO2005017529A1 (en) * | 2003-07-29 | 2005-02-24 | Genentech, Inc. | Assay for human anti cd20 antibodies and uses therefor |
| TWI333977B (en) | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| PE20071101A1 (es) | 2005-08-31 | 2007-12-21 | Amgen Inc | Polipeptidos y anticuerpos |
| JP5205597B2 (ja) * | 2007-06-01 | 2013-06-05 | 静岡県 | １細胞レベルでの抗体遺伝子の解析・同定方法 |
| RU2011117213A (ru) * | 2008-09-30 | 2012-11-10 | Эббот Лэборетриз (Us) | Улучшенные библиотеки антител |
| CA2751669C (en) * | 2009-02-20 | 2017-11-21 | F. Hoffmann-La Roche Ag | Method for obtaining immunoglobulin encoding nucleic acid |
| CA2841475C (en) * | 2011-07-12 | 2021-02-09 | Xbiotech Inc. | Identifying affinity-matured human antibodies |
-
2012
- 2012-07-12 CA CA2841475A patent/CA2841475C/en active Active
- 2012-07-12 JP JP2014520314A patent/JP6731702B2/ja active Active
- 2012-07-12 RU RU2014102617A patent/RU2636045C2/ru active
- 2012-07-12 EP EP15196994.6A patent/EP3034513B1/en active Active
- 2012-07-12 CN CN201610954453.7A patent/CN107090459A/zh active Pending
- 2012-07-12 CN CN201280034673.8A patent/CN103687873B/zh active Active
- 2012-07-12 EP EP12811637.3A patent/EP2731965A4/en not_active Withdrawn
- 2012-07-12 WO PCT/US2012/046431 patent/WO2013009967A2/en not_active Ceased
- 2012-07-12 MX MX2014000431A patent/MX361600B/es active IP Right Grant
- 2012-07-12 US US13/547,497 patent/US9234030B2/en active Active
- 2012-07-12 AU AU2012281078A patent/AU2012281078B2/en active Active
- 2012-07-12 RU RU2017134418A patent/RU2762685C2/ru active
- 2012-07-12 KR KR1020147003416A patent/KR102139388B1/ko active Active
-
2014
- 2014-01-07 IL IL230358A patent/IL230358B/en active IP Right Grant
- 2014-01-10 MX MX2018015450A patent/MX2018015450A/es unknown
-
2015
- 2015-11-12 US US14/939,454 patent/US9453217B2/en active Active
- 2015-11-13 US US14/940,537 patent/US9394536B2/en active Active
-
2016
- 2016-08-26 US US15/248,413 patent/US9670483B2/en active Active
-
2017
- 2017-05-02 US US15/584,360 patent/US20170233457A1/en not_active Abandoned
- 2017-08-03 AU AU2017210585A patent/AU2017210585B2/en active Active
-
2018
- 2018-11-13 IL IL262977A patent/IL262977B/en active IP Right Grant
-
2019
- 2019-11-19 US US16/688,666 patent/US20200071388A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018015450A (es) | Identificacion de anticuerpos humanos con maduracion de afinidad. | |
| Karlikow et al. | CRISPR-induced DNA reorganization for multiplexed nucleic acid detection | |
| ES2875579T3 (es) | Plataforma de ingeniería genómica de HTP para mejorar Escherichia coli | |
| He et al. | Cas3 protein—a review of a multi-tasking machine | |
| Brind’Amour et al. | An ultra-low-input native ChIP-seq protocol for genome-wide profiling of rare cell populations | |
| Gupta et al. | Basic and applied aspects of biotechnology | |
| MY204975A (en) | Complex surface-bound transposome complexes | |
| Benz et al. | Type IV-A3 CRISPR-Cas systems drive inter-plasmid conflicts by acquiring spacers in trans | |
| BR112020006757A2 (pt) | diagnóstico baseado no sistema de efetor crispr | |
| SA523441205B1 (ar) | التحرير المتعدد للجينوم | |
| WO2015160895A3 (en) | Modified transposases for improved insertion sequence bias and increased dna input tolerance | |
| CA3062698A1 (en) | Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof | |
| NZ781020A (en) | Humanized universal light chain mice | |
| WO2013023176A3 (en) | Polymerase compositions, methods of making and using same | |
| US12503704B2 (en) | Modified cell | |
| JP2014521316A5 (enExample) | ||
| EP4428528A3 (en) | Labeled nucleotide compositions and methods for nucleic acid sequencing | |
| Xu et al. | Gene activation by a CRISPR-assisted trans enhancer | |
| MX2020001998A (es) | Tecnología de alteración específica de secuencia objetivo utilizando reconocimiento de objetivos del nucleotído. | |
| Blanch-Asensio et al. | In vitro assembly of plasmid DNA for direct cloning in Lactiplantibacillus plantarum WCSF1 | |
| Kinimi et al. | Complete genome sequencing of field isolates of Peste des petits ruminants virus from Tanzania revealed a high nucleotide identity with lineage III PPR viruses | |
| Bartoccetti et al. | Regulatory dynamics of Tet1 and Oct4 resolve stages of global DNA demethylation and transcriptomic changes in reprogramming | |
| Yeom et al. | Cell-free bacteriophage genome synthesis using low-cost sequence-verified array-synthesized oligonucleotides | |
| SG11201809242VA (en) | Method for increasing mutation introduction efficiency in genome sequence modification technique, and molecular complex to be used therefor | |
| Zhao et al. | Achieving optimal transfection conditions in chicken primordial germ cells under feeder-and serum-free medium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |